{
    "nctId": "NCT03358589",
    "briefTitle": "Molecular Evaluation in Metastatic Breast Cancer",
    "officialTitle": "Molecular Evaluation in Metastatic Breast Cancer - A Clinical Study of Accuracy and Response Assessment",
    "overallStatus": "UNKNOWN",
    "conditions": "Metastatic Breast Cancer, Molecular Imaging",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 270,
    "primaryOutcomeMeasure": "Sensitivity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women\n* Age \\> 18\n* Suspicion of recurrence of earlier breast cancer or new breast cancer diagnose with high risk of metastatic disease\n* Life expectancy \\> 3 month\n* Signed statement of consent\n\nExclusion Criteria:\n\n* Men\n* Pregnancy\n* Severe Medical conditions\n* severe mental og psychological conditions\n* contraindications for MRI (for patients with bone metastasis)\n* treatment for other malignant diseases within the last 5 years prior to inclusion (except carcinoma in situ cervicis uteri and basal cell carcinoma (BCC))",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}